Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock
Boston Scientific has agreed to buy thrombectomy company Penumbra for about $15 billion in cash and stock in a deal that bolsters its cardiovascular portfolio.
Source link
Get latast news super fast
